2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$6.58+$0.10 (+1.48%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.4BMarket Cap
- -42.86%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$6.58+$0.10 (+1.48%)
Earnings Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 17.58% | ||
12-Month Momentum | -10.79% | ||
3-Month Risk Adjusted Momentum | 79.12% | ||
12-Month Risk Adjusted Momentum | -15.57% |
True Yield
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 3 |